financetom
Business
financetom
/
Business
/
Data localisation not the best solution; compliance to laws top priority: Visa CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Data localisation not the best solution; compliance to laws top priority: Visa CEO
Mar 11, 2022 12:24 PM

The RBI mandate on data localisation is not the best solution to address concerns regarding information security, global cards major Visa said on Friday. However, the company's chief executive Alfred F Kelly Jr made it clear that it believes in compliance with the local laws.

Share Market Live

NSE

Its rivals Mastercard and American Express have been penalised for failing to comply with the data localisation requirement, which also included a temporary halt on issuing new cards. "So there are countries like India who have decided that one of the ways to protect data is to localise it. I don't necessarily think that is necessarily the best answer," Kelly said while speaking at the Global Business Summit here.

"...we've worked very hard to make sure that we are compliant with the data localisation rules that were put in place by the RBI. We also look at our role in the ecosystem with regulators in the case, sometimes with top competitors, to make sure that we are doing things that are good for the overall ecosystem," he added. Kelly said his company witnessed 40 percent growth last year and now enjoys a 50 percent market share in India.

Also Read

| How to make payments via UPI123Pay without the internet

To a question on competition, especially from the National Payments Corporation of India's successful UPI platform, he said Visa does not feel threatened by it. "And I actually look at the RBI as one of the more progressive regulators around the world. I think the RBI is a leader in trying to displace cash. They are a leader in trying to introduce more protections into the ecosystem," he noted, adding that compliance to regulations is the top priority for the company.

Replying to another question, Kelly said India has undertaken phenomenal changes in the last five years since demonetisation and added that regulators are trying to figure out what are the right things to do. "I think the intentions of the RBI are very positive. I think the RBI tends to listen well. But that said, there have been times where there's been some lack of clarity or a change in position from time to time that makes it challenging. But again, that happens in other markets as well," he said.

There have been many regulatory changes because data has emerged as a new frontier or a powerful ingredient which helps companies gain competitive advantage, he added.

First Published:Mar 11, 2022 9:24 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Andlauer Healthcare to Launch Normal Course Issuer Bid
Andlauer Healthcare to Launch Normal Course Issuer Bid
Jun 27, 2024
09:00 AM EDT, 06/27/2024 (MT Newswires) -- Andlauer Healthcare Group ( ANDHF ) said Thursday that it secured TSX approval for a normal course issuer bid (NCIB) for up to 10% of its public float over the next 12 months. The company said it can purchase its shares for cancellation beginning on July 2 and until July 1, 2025. Andlauer...
Spice maker McCormick beats quarterly results on strong EMEA business
Spice maker McCormick beats quarterly results on strong EMEA business
Jun 27, 2024
(Reuters) - McCormick ( MKC ) beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out, improving volumes across the company's consumer segment, its biggest unit. Consumer sales in Europe, Middle East and...
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
Jun 27, 2024
June 27 (Reuters) - Benson Hill Inc ( BHIL ): * ARGONAUTIC VENTURES - PRELIMINARY NON-BINDING PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION BY TO-BE-FORMED ACQUISITION VEHICLE * ARGONAUTIC VENTURES-PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION ALL OF OUTSTANDING SHARES FOR CASH CONSIDERATION OF $0.2236/SHARE Source text for Eikon: Further company coverage: ...
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Jun 27, 2024
June 27 (Reuters) - Verona Pharma's therapy for treating a chronic lung disease will be sold in the U.S. at a wholesale price of $2,950 per month, the U.K.-based company said on a conference call on Thursday. The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, provides a new inhaled non-steroidal treatment for chronic obstructive pulmonary...
Copyright 2023-2026 - www.financetom.com All Rights Reserved